Previous Article | Next Article 
Applied and Environmental Microbiology, October 2001, p. 4930-4933, Vol. 67, No. 10
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.10.4930-4933.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Vancomycin-Resistant Enterococcus spp. Isolated from
Wastewater and Chicken Feces in the United States
Valerie J.
Harwood,*
Miriam
Brownell,
William
Perusek, and
John E.
Whitlock
Department of Biology, University of South
Florida, Tampa, Florida 33620
Received 5 March 2001/Accepted 18 July 2001
 |
ABSTRACT |
Vancomycin-resistant Enterococcus spp. (VRE) were
isolated from sewage and chicken feces but not from other animal fecal
sources (dog, cow, and pig) or from surface waters tested. VRE from
hospital wastewater were resistant to
20 µg of vancomycin/ml and
possessed the vanA gene. VRE from residential wastewater
and chicken feces were resistant to 3 to 5 µg of vancomycin/ml and
possessed the vanC gene.
 |
TEXT |
Vancomycin resistance in
Enterococcus species is becoming a major concern in clinical
settings as the rate of occurrence of vancomycin-resistant
Enterococcus spp. (VRE) implicated in disease increases. For example, by 1999 the incidence of VRE-mediated nosocomial infections in intensive care units had increased 43% from
that of the period of 1994 to 1998 (23).
Enterococcus faecalis and E. faecium are reported
more frequently as etiological agents of disease than are other
enterococci (14, 15), but other species, such as E. avium (25), occasionally cause disease.
Several operons that mediate vancomycin resistance in
Enterococcus spp. have been identified. Perhaps the most
significant from an epidemiological standpoint is
vanA-mediated vancomycin resistance, as these genes are
carried on transposon Tn1546 (4) and confer
inducible high-level resistance to vancomycin and teicoplanin (19). The chromosomally encoded phenotype mediated by the
vanC gene is marked by low-level resistance to vancomycin
(20) and is an intrinsic characteristic of E. gallinarum (11), E. casseliflavus, and
E. flavescens (24).
VRE that are resistant to high levels of vancomycin can be readily
isolated from the feces of domestic animals in Europe (2, 10) and from humans with no exposure to hospitals (17,
31). There has been no report of high-level vancomycin
resistance (>32 µg/ml) in Enterococcus spp. from animal
feces or from humans without hospital exposure in the United States. In
spite of a 1997 call for the investigation of sources of VRE outside
the health care setting in the United States (21), there
are remarkably few publications containing such data (8).
VRE that are intrinsically resistant to low levels of vancomycin, such
as E. gallinarum, E. casseliflavus, and E. flavescens, have been isolated from bird feces (30),
and E. gallinarum containing the vanC gene has
been isolated from chickens and farm lagoons (8).
As part of another study (18), our laboratory isolated
thousands of fecal streptococci (a group that includes
Enterococcus spp. and other group D Streptococcus
spp.) from animal feces, wastewater, and surface waters. Some of these
isolates were resistant to high levels (>32 µg/ml) of vancomycin. In
order to investigate the presence of VRE in wastewater, animal feces,
and surface waters, all VRE were identified to the genus and species level.
Isolation of vancomycin-resistant fecal streptococci.
Fecal
streptococcus isolates were obtained from the feces of cattle,
chickens, dogs, pigs, and wild animals (birds and raccoons). Fecal
streptococci were also isolated from wastewater samples collected at a
central sewer lift station (designated LF) serving residential
neighborhoods (sample LF1) (Table 1) and
from a line connecting a hospital to the main sewer line (hospital
wastewater samples 1 and 2) (Table 1) in Tampa, Fla. Surface water
samples were collected from three major tributaries of the St.
Johns River in Jacksonville, Fla, and from the Hillsborough River
in Tampa, Fla.
Fecal streptococci were isolated by membrane filtration followed by
incubation with selective-differential media. For stool
samples,
1.0 g of feces was dissolved in 100 ml of phosphate-buffered
saline (PBS) (pH 7.2) followed by thorough homogenization by vortexing.
Subsequent dilutions over several orders of magnitude were made
from
the homogenate. Wastewater samples were similarly vortexed
and diluted in PBS. A volume of 0.1 to 100 ml of each surface
water
sample, depending upon the contamination level at the site,
was
analyzed. Each sample was filtered through a 0.45-µm-pore-size
membrane, which was placed on a sterile filter paper pad soaked
with Enterococcosel broth (BBL) and incubated at 37°C for
24 h.
The colonies were individually transferred with sterile
toothpicks
to a 96-well microtiter plate whose wells each contained 200 µl
of Enterococcosel broth and were incubated at 37°C for 24 h. Isolates
in wells that turned black or dark brown, indicating
esculin hydrolysis,
were transferred by a replica plating device to
Trypticase soy
agar plates amended with 10 µg of vancomycin/ml. All
sources except
the cattle feces yielded some colonies with the ability
to grow
on vancomycin-amended plates (Table
1). Isolates that displayed
growth on the vancomycin-amended plates were subjected to further
biochemical
testing.
Fecal streptococci that grew on vancomycin-amended media were subjected
to preliminary tests to determine their membership
in the genus
Enterococcus, including Gram staining and growth
in brain
heart infusion broth (Becton Dickinson, Cockeysville,
Md.) with 6.5%
NaCl (35°C), at pH 9.6 (35°C), and at 45°C (
3).
Most
isolates from surface waters and animal feces were determined
not to
belong to the genus
Enterococcus (Table
1). Isolates that
passed the preliminary
Enterococcus tests were assayed for
leucine
aminopeptidase (LAP) and pyroglutamyl aminopeptidase (PYR)
activity
using the BactiCard Strep test kit (Remel, Inc., Lenexa,
Kans.).
These tests differentiate
Enterococcus species from
members of
the intrinsically vancomycin-resistant genera
Leuconostoc,
Pediococcus,
and
Weissella (
13). Isolates from dog feces were
PYR

and were identified as members of the genus
Weissella (Table
1). All of the isolates from chicken feces
and hospital wastewater
and some of the isolates from residential
wastewater were PYR
+ and LAP
+, confirming their
membership in the genus
Enterococcus. Confirmed
VRE isolates
were identified to the species level with the API
Strep biochemical
test system (BioMerieux, St. Louis, Mo.)
Detection of VRE by primary isolation on vancomycin-amended
media.
Presumptive VRE were also isolated from wastewater by
plating directly on vancomycin-amended mEI agar
(34) (3 or 10 µg/ml; Table 1). The LF lift station
was described above, and samples LF2 and LF3 were taken on
separate dates at the LF lift station. Wastewater was also
sampled at a second residential lift station (designated TP), which was
not connected by flow to the LF lift station. The sampling events for
each of the residential wastewater samples were approximately 2 months apart.
One milliliter of wastewater was suspended in 50 ml of PBS. Each sample
was filtered onto a membrane filter (pore size, 0.45
µm), which was
transferred to mEI agar amended with vancomycin
(10 µg/ml) and
incubated at 41°C for 24 h. No vancomycin-resistant
Enterococcus isolates were obtained from residential
wastewater
screened against 10 µg of vancomycin/ml (isolate LF2,
Table
1).
Two samples (LF3 and TP) were therefore filtered and cultured
on mEI agar amended with 3 µg of vancomycin/ml at 41°C for 24
h. The subsequent processing steps were the same for all isolates.
Colonies were transferred with sterile toothpicks to microtiter
dish
wells containing 180 µl of Enterococcosel broth. These cultures
were
incubated at 41°C for 24 h. Growth from the microtiter dishes
was transferred with a replicator to Mueller-Hinton agar plates
amended
with 3 (samples LF3 and TP) or 10 µg of vancomycin/ml,
and the plates
were incubated for 24 h at 41°C.
Presumptive VRE isolates were confirmed as described above and
were identified to the species level with the API Strep system.
PCR was
used to assess the genotype of each VRE isolate. The
vanA,
vanB, and
vanC genes were
targeted with specific primers (
7)
in separate PCRs. The
primer sequences for
vanA were (5'

3') CAT
GAA TAG
AAT AAA AGT TGC AAT A and CCC CTT TAA CGC TAA TAC GAT
CAA;
for
vanB, they were GTG ACA AAC CGG AGG CGA GGA
and CCG CCA
TCC TCC TGC AAA AAA; and for
vanC, they were GAA AGA CAA CAG GAA
GAC CGC and
ATC GCA TCA CAA GCA CCA ATC. Positive controls were
E. faecalis A256 for VanA,
E. faecalis V583
for VanB, and
E. gallinarum VR-42 for VanC. These
combinations of primer sets and control
strains produced
PCR products of ca. 1,030, 433, and 796 bp, respectively,
as
expected based on the literature (
7). PCR products of the
correct size were obtained from hospital wastewater isolates using
the
vanA-specific primers and from the chicken feces and
residential
wastewater isolates using the
vanC-specific
primers. DNA from
each VRE could be amplified with only one primer set
(data not
shown).
To confirm the specificity of PCR, amplicons were sequenced and aligned
with DNA sequences in GenBank using BLAST 2.1 (National
Center for
Biotechnology Information). The PCR product from each
strain was
purified using the QIAquick DNA purification kit (Qiagen,
Valencia,
Calif.). The first primer of each set for PCR (see above)
was used for
DNA sequencing of the PCR product. Cycle sequencing
was carried out
with an ABI model 310 automated sequencer (Perkin-Elmer,
Boston Mass.).
The DNA sequences of the
vanA PCR amplicon and
the
vanC PCR amplicon demonstrated over 90% identity with
representative
sequences in GenBank. The
vanA amplicon was
aligned with the
E. faecium plasmid pIP816
vanA
gene sequence (GenBank accession no.
X56895) (
12), and the
vanC amplicon was aligned with the
E. gallinarum
vanC gene sequence (GenBank accession no.
AF162694)
(
11).
The MICs of vancomycin, ampicillin, erythromycin, and tetracycline for
VRE isolates were determined by the broth microdilution
method as
described in National Committee for Clinical Laboratory
Standards
guidelines. The end points of the antibiotic series
used in these
experiments were defined by previously published
breakpoints
corresponding to full clinical resistance or susceptibility
for
Enterococcus (
22). The three VRE isolates from
hospital
wastewater that were identified as
E. avium (Table
2) displayed
resistance to erythromycin
(>10 µg/ml) as well as to vancomycin
(20 to 32 µg/ml). Coupled
resistance to vancomycin (

32 µg/ml)
and erythromycin (

8 µg/ml)
has been previously noted in
E. faecium isolates harboring
the
vanA gene (
1) but not, to the best of
our
knowledge, in
E. avium. Two of the
vancomycin-resistant
E. avium strains displayed unstable
resistance in that they were
resistant to 64 µg of vancomycin/ml when
first isolated but displayed
successively less resistance when
subcultured in the presence
of vancomycin. Their resistance to 20 µg
of vancomycin/ml, however,
was stable.
The two
E. faecalis isolates from hospital wastewater were
also resistant to erythromycin. The three residential wastewater
isolates, which were identified as
E. gallinarum, were
resistant
to low levels of vancomycin, and two of the
E. gallinarum isolates
were resistant to tetracycline. The
E. gallinarum isolates from
chicken feces were lost in a laboratory
accident before they were
tested for resistance to other
antibiotics.
Enterococcus species that were resistant to high levels of
vancomycin could be readily isolated from hospital wastewater even
without the use of vancomycin during the initial screening (Table
1).
Enterococci resistant to low levels of vancomycin were isolated
in the
same manner from chicken feces, demonstrating their relatively
high
prevalence. It was necessary to screen residential wastewater
isolates
on vancomycin-amended media in order to isolate low-level
VRE, and no
high-level VRE were found in residential wastewater.
It should be noted
that this screening was not exhaustive and
serves mainly to illustrate
the vastly higher frequency of occurrence
of VRE in hospital wastewater
than in residential wastewater in
this Florida community. For
comparison, a study in Spain noted
a much lower frequency of high-level
VRE (0.4%) in wastewater
entering a main treatment plant
(
33) than demonstrated here
for hospital wastewater (6.25 and 5.21% for two samples). However,
VRE were present at a higher
frequency than was measured for residential
wastewater in this study.
In France, 3.7% of enterococci isolated
from fecal samples of
hematology patients and 1.8% of enterococci
isolated from fecal
samples of a control outpatient group were
resistant to high levels
(

16 µg/ml) of vancomycin (
17).
Although one tends to think of wastewater that has entered a central
sewer collection system as well-contained, breaches in
the integrity of
such systems can contribute to the contamination
of natural waters by
pathogens and indicator organisms. Infiltration,
or the flow of
groundwater into wastewater collection systems
when soils are saturated
with water, is a major problem in wastewater
management, increasing the
cost and decreasing the efficiency
of wastewater treatment (
32,
35). The converse of infiltration
can also occur; that is,
sewage may leak out of cracked pipes
when groundwater levels are low,
and microorganisms can be transported
to groundwater or surface water
under appropriate hydrological
conditions. Combined sewer overflow
systems, which handle both
sewage and stormwater, can allow the release
of microorganisms
to surface water during storm
events.
VRE that are resistant to high levels of vancomycin may well still be
uncommon outside health care settings in the United
States, as
demonstrated by the failure to isolate high-level VRE
from
residential wastewater in this study. However, each of the
vancomycin-resistant
Enterococcus species isolated during
this
study, including
E. gallinarum, has been implicated in
disease.
E. faecalis is one of the major pathogens of the
genus, while
E. avium (
9,
25-27) and
E. gallinarum (
28,
36) are documented
etiological agents
of endocarditis and bacteremia. Intrinsically
resistant VRE such as
E. gallinarum can be particularly troublesome,
as in vitro
tests may indicate vancomycin susceptibility in
E. gallinarum isolates that are resistant to treatment in vivo
(
28).
Epidemiological evidence from Europe suggests that VRE are horizontally
transmitted from animals to humans (
5,
6,
31).
The
transmissibility of VRE by nonnosocomial routes, coupled with
the
difficulties encountered in treating infections caused by
VRE,
indicates that great care should be taken to avoid introducing
these
organisms into the environment. Such contamination can occur
during
sewage spills or as the result of other, less obvious failures
of
wastewater systems, such as leaky collection lines or ineffective
on-site (septic) systems. Public health may be threatened by VRE
release, particularly if the organisms reach groundwater, which
may be
consumed without treatment, or if they impact recreational
waters.
Evidence exists that
Enterococcus spp. can proliferate
in
subtropical and tropical soils and waters (
16,
29);
therefore,
introduction of VRE into such environments may be especially
problematic.
This study found that high-level VRE could be isolated without
enrichment or screening on antibiotics from hospital wastewater
but not
from residential wastewater. Much less is known about
the distribution
of VRE in healthy humans in the United States
than in Europe, and
almost no information exists on the survival
and growth of VRE that are
released into natural waters. Accurate
assessment of the magnitude of
the public health threat represented
by VRE in wastewater depends upon
further investigation of these
questions.
 |
ACKNOWLEDGMENTS |
We thank F. C. Tenover, Centers for Disease Control and
Prevention, for vancomycin-resistant control strains and James Garey, USF Department of Biology, for DNA sequencing.
Funding for this work was provided in part by an American Society for
Microbiology Undergraduate Research Fellowship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biology, SCA 110, University of South Florida, 4202 E. Fowler Ave.,
Tampa, FL 33620. Phone: (813) 974-1524. Fax: (813) 974-3263. E-mail: vharwood{at}chumal.cas.usf.edu.
 |
REFERENCES |
| 1.
|
Aarestrup, F. M.,
Y. Agerso,
P. Gerner-Smidt,
M. Madsen, and L. B. Jensen.
2000.
Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark.
Diagn. Microbiol. Infect. Dis.
37:127-137[CrossRef][Medline].
|
| 2.
|
Aarestrup, F. M.,
F. Bager,
N. E. Jensen,
M. Madsen,
A. Meyling, and H. C. Wegener.
1998.
Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark.
APMIS
106:606-622[Medline].
|
| 3.
|
American Public Health Association.
1995.
Standard methods for the examination of water and wastewater, 19th ed.
American Public Health Association, Washington, D.C.
|
| 4.
|
Arthur, M.,
C. Molinas,
F. Depardieu, and P. Courvalin.
1993.
Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.
J. Bacteriol.
175:117-127[Abstract/Free Full Text].
|
| 5.
|
Bates, J.
1997.
Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection.
J. Hosp. Infect.
37:89-101[CrossRef][Medline].
|
| 6.
|
Bates, J.,
Z. Jordens, and J. B. Selkon.
1993.
Evidence for an animal origin of vancomycin-resistant enterococci.
Lancet
342:490-491[Medline].
|
| 7.
|
Clark, N. C.,
R. C. Cooksey,
B. C. Hill,
J. M. Swenson, and F. C. Tenover.
1993.
Characterization of glycopeptide-resistant enterococci from U.S. hospitals.
Antimicrob. Agents Chemother.
37:2311-2317[Abstract/Free Full Text].
|
| 8.
|
Coque, T. M.,
J. F. Tomayko,
S. C. Ricke,
P. C. Okhyusen, and B. E. Murray.
1996.
Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States.
Antimicrob. Agents Chemother.
40:2605-2609[Abstract].
|
| 9.
|
Das, I., and J. Gray.
1998.
Enterococcal bacteremia in children: a review of seventy-five episodes in a pediatric hospital.
Pediatr. Infect. Dis. J.
17:1154-1158[CrossRef][Medline].
|
| 10.
|
Devriese, L. A.,
M. Ieven,
H. Goossens,
P. Vandamme,
B. Pot,
J. Hommez, and F. Haesebrouck.
1996.
Presence of vancomycin-resistant enterococci in farm and pet animals.
Antimicrob. Agents Chemother.
40:2285-2287[Abstract].
|
| 11.
|
Dutka-Malen, S.,
C. Molinas,
M. Arthur, and P. Courvalin.
1992.
Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance.
Gene
112:53-58[CrossRef][Medline].
|
| 12.
|
Dutka-Malen, S.,
C. Molinas,
M. Arthur, and P. Courvalin.
1990.
The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes.
Mol. Gen. Genet.
224:364-372[Medline].
|
| 13.
|
Facklam, R.,
N. Pigott,
R. Franklin, and J. Elliott.
1995.
Evaluation of three disk tests for identification of enterococci, leuconostocs, and pediococci.
J. Clin. Microbiol.
33:885-887[Abstract].
|
| 14.
|
Franz, C. M.,
W. H. Holzapfel, and M. E. Stiles.
1999.
Enterococci at the crossroads of food safety?
Int. J. Food Microbiol.
47:1-24[CrossRef][Medline].
|
| 15.
|
Frieden, T. R.,
S. S. Munsiff,
D. E. Low,
B. M. Willey,
G. Williams,
Y. Faur,
W. Eisner,
S. Warren, and B. Kreiswirth.
1993.
Emergence of vancomycin-resistant enterococci in New York City.
Lancet
342:76-79[CrossRef][Medline].
|
| 16.
|
Fujioka, R. S.,
C. Sian-Denton,
M. Borja,
J. Castro, and K. Morphew.
1999.
Soil: the environmental source of Escherichia coli and enterococci in Guam's streams.
J. Appl. Microbiol. Symp. Suppl.
85:83S-89S.
|
| 17.
|
Gambarotto, K.,
M.-C. Ploy,
P. Turlure,
C. Grélaud,
C. Martin,
D. Bordessoule, and F. Denis.
2000.
Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.
J. Clin. Microbiol.
38:620-624[Abstract/Free Full Text].
|
| 18.
|
Harwood, V. J.,
J. Whitlock, and V. Withington.
2000.
Classification of antibiotic resistance patterns of indicator bacteria by discriminant analysis: use in predicting the source of fecal contamination in subtropical waters.
Appl. Environ. Microbiol.
66:3698-3704[Abstract/Free Full Text].
|
| 19.
|
Leclercq, R.,
E. Derlot,
M. Weber,
J. Duval, and P. Courvalin.
1989.
Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.
Antimicrob. Agents Chemother.
33:10-15[Abstract/Free Full Text].
|
| 20.
|
Leclercq, R.,
S. Dutka-Malen,
J. Duval, and P. Courvalin.
1992.
Vancomycin resistance gene vanC is specific to Enterococcus gallinarum.
Antimicrob. Agents Chemother.
36:2005-2008[Abstract/Free Full Text].
|
| 21.
|
McDonald, L. C.,
M. J. Kuehnert,
F. C. Tenover, and W. R. Jarvis.
1997.
Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.
Emerg. Infect. Dis.
3:311-317[Medline].
|
| 22.
|
National Committee for Clinical Laboratory Standards.
2001.
Performance standards for antimicrobial susceptibility testing, 11th informational supplement, vol. 21.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 23.
|
National Nosocomial Infections Surveillance System.
1999.
National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999.
Am. J. Infect. Control
27:520-532[CrossRef][Medline].
|
| 24.
|
Navarro, F., and P. Courvalin.
1994.
Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens.
Antimicrob. Agents Chemother.
38:1788-1793[Abstract/Free Full Text].
|
| 25.
|
Patel, R.,
M. R. Keating,
F. R. Cockerill III, and J. M. Steckelberg.
1993.
Bacteremia due to Enterococcus avium.
Clin. Infect. Dis.
17:1006-1011[Medline].
|
| 26.
|
Pearce, C. L.,
M. K. Evans,
S. M. Peters, and M. F. Cole.
1998.
Clonal diversity of vancomycin-resistant enterococci from an outbreak in a tertiary care university hospital.
Am. J. Infect. Control
26:563-568[CrossRef][Medline].
|
| 27.
|
Perez-Castrillon, J. L.,
M. Martin-Luquero,
J. C. Martin-Escudero,
P. Pascual,
A. Casero, and V. Herreros.
1997.
Endocarditis caused by Enterococcus avium.
Scand. J. Infect. Dis.
29:530[Medline].
|
| 28.
|
Reid, K. C.,
I. F. Cockerill, and R. Patel.
2001.
Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases.
Clin. Infect. Dis.
32:1540-1546[CrossRef][Medline].
|
| 29.
|
Roll, B. M., and R. S. Fujioka.
1997.
Sources of faecal indicator bacteria in a brackish, tropical stream and their impact on recreational water quality.
Water Sci. Technol.
35:179-186.
|
| 30.
|
Sellin, M.,
H. Palmgren,
T. Broman,
S. Bergstrom, and B. Olsen.
2000.
Involving ornithologists in the surveillance of vancomycin-resistant enterococci.
Emerg. Infect. Dis.
6:87-88[Medline].
|
| 31.
|
Stobberingh, E.,
A. van den Bogaard,
N. London,
C. Driessen,
J. Top, and R. Willems.
1999.
Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of The Netherlands: evidence for transmission of vancomycin resistance from animals to humans?
Antimicrob. Agents Chemother.
43:2215-2221[Abstract/Free Full Text].
|
| 32.
|
Tchobanoglous, G. (ed.).
1981.
Wastewater engineering: collection and pumping of wastewater.
McGraw-Hill, New York, N.Y.
|
| 33.
|
Torres, C.,
J. A. Reguera,
M. J. Sanmartin,
J. C. Perez-Diaz, and F. Baquero.
1994.
vanA-mediated vancomycin-resistant Enterococcus spp. in sewage.
J. Antimicrob. Chemother.
33:553-561[Abstract/Free Full Text].
|
| 34.
|
U.S. Environmental Protection Agency.
1997.
EPA method 1600: membrane filter test method for enterococci in water. EPA-821-R-97-004. U.S.
Environmental Protection Agency, Washington, D.C.
|
| 35.
|
U.S. Environmental Protection Agency.
1991.
Sewer system infrastructure analysis and rehabilitation. Handbook EPA-625-6-91-030. U.S.
Environmental Protection Agency, Washington, D.C.
|
| 36.
|
Yoshimoto, E.,
M. Konishi,
K. Takahashi,
T. Majima,
K. Ueda,
K. Murakawa,
M. Sakamoto,
K. Maeda,
K. Mikasa,
N. Narita,
R. Sano,
T. Masutani,
Y. Ishii, and K. Yamaguchi.
1999.
Enterococcus gallinarum septicemia in a patient with acute myeloid leukemia.
Kansenshogaku Zasshi
73:1078-1081[Medline].
|
Applied and Environmental Microbiology, October 2001, p. 4930-4933, Vol. 67, No. 10
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.10.4930-4933.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Graham, M., Ballard, S. A., Grabsch, E. A., Johnson, P. D. R., Grayson, M. L.
(2008). High Rates of Fecal Carriage of Nonenterococcal vanB in both Children and Adults. Antimicrob. Agents Chemother.
52: 1195-1197
[Abstract]
[Full Text]
-
Poole, T. L., Hume, M. E., Campbell, L. D., Scott, H. M., Alali, W. Q., Harvey, R. B.
(2005). Vancomycin-Resistant Enterococcus faecium Strains Isolated from Community Wastewater from a Semiclosed Agri-Food System in Texas. Antimicrob. Agents Chemother.
49: 4382-4385
[Abstract]
[Full Text]
-
Novais, C., Coque, T. M., Ferreira, H., Sousa, J. C., Peixe, L.
(2005). Environmental Contamination with Vancomycin-Resistant Enterococci from Hospital Sewage in Portugal. Appl. Environ. Microbiol.
71: 3364-3368
[Abstract]
[Full Text]
-
Hayes, J. R., English, L. L., Carr, L. E., Wagner, D. D., Joseph, S. W.
(2004). Multiple-Antibiotic Resistance of Enterococcus spp. Isolated from Commercial Poultry Production Environments. Appl. Environ. Microbiol.
70: 6005-6011
[Abstract]
[Full Text]
-
Kummerer, K.
(2004). Resistance in the environment. J Antimicrob Chemother
54: 311-320
[Abstract]
[Full Text]
-
Guardabassi, L., Dalsgaard, A.
(2004). Occurrence, Structure, and Mobility of Tn1546-Like Elements in Environmental Isolates of Vancomycin-Resistant Enterococci. Appl. Environ. Microbiol.
70: 984-990
[Abstract]
[Full Text]
-
Phillips, I., Casewell, M., Cox, T., De Groot, B., Friis, C., Jones, R., Nightingale, C., Preston, R., Waddell, J.
(2004). Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother
53: 28-52
[Abstract]
[Full Text]
-
Hayes, J. R., English, L. L., Carter, P. J., Proescholdt, T., Lee, K. Y., Wagner, D. D., White, D. G.
(2003). Prevalence and Antimicrobial Resistance of Enterococcus Species Isolated from Retail Meats. Appl. Environ. Microbiol.
69: 7153-7160
[Abstract]
[Full Text]
-
Simjee, S., White, D. G., McDermott, P. F., Wagner, D. D., Zervos, M. J., Donabedian, S. M., English, L. L., Hayes, J. R., Walker, R. D.
(2002). Characterization of Tn1546 in Vancomycin-Resistant Enterococcus faecium Isolated from Canine Urinary Tract Infections: Evidence of Gene Exchange between Human and Animal Enterococci. J. Clin. Microbiol.
40: 4659-4665
[Abstract]
[Full Text]
-
Iversen, A., Kuhn, I., Franklin, A., Mollby, R.
(2002). High Prevalence of Vancomycin-Resistant Enterococci in Swedish Sewage. Appl. Environ. Microbiol.
68: 2838-2842
[Abstract]
[Full Text]